Education

Awareness

Research

Volunteer

Donate

Home

Chiari Research Conference 2008 Details & Agenda (PDF)

Chiari Malformation:  State of the Research & New Directions:
A two day professional research conference, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS), the Office of Rare Diseases, the University of Illinois-Chicago, the University of Akron, Conquer Chiari, Column of Hope, and the American Syringomyelia Alliance Project, which will bring together the top physicians and researchers in the field in order to establish the current state of knowledge regarding Chiari malformation, discuss recent developments in Chiari research, and develop research recommendations to advance the state of knowledge and care for Chiari malformation. The meeting will include review presentations, new research presentations, and breakout working group sessions on: Definition & Pathophysiology, Symptoms & Diagnostic Criteria, Engineering & Imaging Techniques, Treatment, Pediatric Issues, and Related Conditions. All participants are invited to participate in the Working Group Sessions.

Date: November 6th & 7th, 2008
Location: Hyatt Regency O’Hare; Chicago, IL
Registration: Registration is free, but space is limited.  Please register below.

Note To Patients:  This conference is a professional event and is reserved for doctors and researchers.  However, the proceeding will be made available to the general public, free of charge, through a video web archive.

On-Line Conference Registration

  Sponsors:

Acknowledgements:  We gratefully acknowledge grants from the following companies in support of this event:

Note: Funding for this conference was made possible (in part) by NS063446 from National Institute of Neurological Disorders and Stroke and the Office of Rare Diseases (ORD). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.